![Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN](https://dynaimage.cdn.cnn.com/cnn/c_fill,g_auto,w_1200,h_675,ar_16:9/https%3A%2F%2Fcdn.cnn.com%2Fcnnnext%2Fdam%2Fassets%2F211230154406-teva-pharmaceuticals-file-2021.jpg)
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
![Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510642830861510679/filePointer/510642830861510701/fodoid/510642830861510696/imageType/MEDIUM/inlineImage/true/Teva-announced-launch-of-new-daily-asthma-medicine.png)
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire](https://mms.businesswire.com/media/20200921005170/en/819864/22/Interactive_Media_Placeholder_highres.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
![Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel](https://static.timesofisrael.com/www/uploads/2022/07/F210107YA03.jpg)
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
![Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions](http://topclassactions.com/wp-content/uploads/2022/03/recallTeva-700x547.jpg)
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions
![Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2022/07/Stock-tevapharmaceuticals-01-adobe.jpg)
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
![Teva Pharmaceuticals on Twitter: "We're at the #AAAAI21 virtual conference this weekend presenting data that explores the extent of uncontrolled #asthma in the U.S. If you're attending, don't forget to visit our Teva Pharmaceuticals on Twitter: "We're at the #AAAAI21 virtual conference this weekend presenting data that explores the extent of uncontrolled #asthma in the U.S. If you're attending, don't forget to visit our](https://pbs.twimg.com/media/EvKFuoBXcAAtxGf.jpg)
Teva Pharmaceuticals on Twitter: "We're at the #AAAAI21 virtual conference this weekend presenting data that explores the extent of uncontrolled #asthma in the U.S. If you're attending, don't forget to visit our
![Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' | Markets Insider Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' | Markets Insider](https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2022/08/05/screen_shot_2022-08-05_at_11.20.19_am.png)
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' | Markets Insider
![Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference | Business Wire Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference | Business Wire](https://mms.businesswire.com/media/20210510005060/en/739014/23/teva_RGB_JPEG.jpg)